FDA Adverse Event Injury Summary report: N

RELIATECT POST-OP DRESSING WITH CHG

MDR report key: 11164618 · Received January 13, 2021

Report

Report Number
3003764829-2021-00001
Event Type
Injury
Date Received
January 13, 2021
Date of Event
October 16, 2020
Report Date
January 12, 2021
Manufacturer
AVERY DENNISON CORPORATION
Product Code
FRO
UDI-DI
00817138010517
PMA / PMN Number
K163529
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

AVERY DENNISON RECEIVED A COMPLAINT FROM THE OB/GYN DEPARTMENT OF A HOSPITAL IN (B)(6) THROUGH ITS DISTRIBUTOR. THE COMPLAINT INDICATED THAT A RASH WAS OBSERVED AFTER THE USE OF THE RELIATECT POST-OP DRESSING WITH CHG ON A PATIENT THAT UNDERWENT A C-SECTION SURGICAL PROCEDURE.     A FOLLOW-UP COMMUNICATION FROM THE HOSPITAL STATED THAT THE RASH WAS MILD IN NATURE AND WAS TREATED WITH A TOPICAL OINTMENT. NO ADDITIONAL TREATMENT WAS REQUIRED. FURTHERMORE, NO PATIENT SENSITIVITY WAS KNOWN PRIOR TO THE USE OF THE POST-OP DRESSING CONTAINING CHG. BASED ON THE NATURE OF THE INCIDENT, RETAIN SAMPLES WERE TESTED FOR PERFORMANCE CHARACTERISTICS. ALL THE RESULTS WERE FOUND TO BE WITHIN SPECIFICATIONS AND NO DEVICE MALFUNCTION WAS IDENTIFIED. IN ADDITION, AVERY DENNISON CONDUCTED A DEVICE HISTORY RECORD REVIEW OF THE REPORTED LOT. THE REVIEW CONFIRMED THAT THE PERFORMANCE CHARACTERISTICS WERE WITHIN SPECIFICATION AT THE TIME OF PRODUCT RELEASE.

Description of Event or Problem · 1

AVERY DENNISON RECEIVED A COMPLAINT FROM THE OB/GYN DEPARTMENT OF A HOSPITAL IN (B)(6) THROUGH ITS DISTRIBUTOR. THE COMPLAINT INDICATED THAT A RASH WAS OBSERVED AFTER THE USE OF THE RELIATECT POST-OP DRESSING WITH CHG ON A PATIENT THAT UNDERWENT A C-SECTION SURGICAL PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
61665 RELIATECT POST-OP DRESSING WITH CHG DRESSING, WOUND, DRUG FRO AVERY DENNISON CORPORATION 0496-0568-76 K0711A01 00817138010517

Patients

Seq Age Sex Outcome Treatment
1 30 YR Other